Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Short Interest Update

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) saw a significant increase in short interest in August. As of August 31st, there was short interest totaling 2,283,272 shares, an increase of 96.4% from the August 15th total of 1,162,372 shares. Based on an average daily volume of 565 shares, the days-to-cover ratio is presently 4,041.2 days.

Shanghai Fosun Pharmaceutical (Group) Stock Performance

OTCMKTS:SFOSF opened at $1.93 on Tuesday. Shanghai Fosun Pharmaceutical has a fifty-two week low of $1.93 and a fifty-two week high of $3.50. The company’s 50-day simple moving average is $2.16 and its 200-day simple moving average is $2.31.

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China?based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small?molecule drugs, bio?pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.